Clinician Training and Parent Text Messages Tested to Improve HPV Vaccination in Children

Human papillomavirus (HPV) is a common virus that can cause several cancers later in life, including cervical, anal and some head-and-neck cancers. HPV vaccination is an important preventive measure because it protects against HPV types responsible for a substantial proportion of these cancers.

Although vaccination is recommended during childhood and early adolescence, uptake can be affected by parental concerns, limited awareness, missed appointments and inconsistent recommendations from healthcare professionals.

The new randomised clinical trial examined whether clinician communication training and text-message outreach to parents could improve HPV vaccination among children aged 10–12.

The research is important because it evaluates practical approaches that healthcare systems can use to address missed vaccination opportunities. Clinician recommendations and clear communication with parents may help families understand the purpose and timing of vaccination.

The study focuses on vaccination strategies rather than testing a new vaccine. Its findings may help improve routine preventive healthcare for children.

Parents should discuss the recommended HPV vaccination schedule with their child's healthcare professional and follow the applicable national immunisation guidance.